The x-ray crystallographic structure of selenomethionyl cytosine-5-monophosphate-acylneuraminate synthetase (CMP-NeuAc synthetase) from Neisseria meningitidis has been determined at 2.0-Å resolution using multiple-wavelength anomalous dispersion phasing, and a second structure, in the presence of the substrate analogue CDP, has been determined at 2.2-Å resolution by molecular replacement. This work identifies the active site residues for this class of enzyme for the first time. The detailed interactions between the enzyme and CDP within the mononucleotide-binding pocket are directly observed, and the acylneuraminate-binding pocket has also been identified. A model of acylneuraminate bound to CMP-NeuAc synthetase has been constructed and provides a structural basis for understanding the mechanism of production of "activated" sialic acids. Sialic acids are key saccharide components on the surface of mammalian cells and can be virulence factors in a variety of bacterial species (e.g. Neisseria, Haemophilus, group B streptococci, etc.). As such, the identification of the bacterial CMP-NeuAc synthetase active site can serve as a starting point for rational drug design strategies.
Cytosine-5Ј-monophosphate-acylneuraminate synthetase (cytosine-5Ј-monophosphate-N-acetyl neuraminic acid synthetase, CMP-NeuAc synthetase) 1 catalyzes the penultimate step in the addition of sialic acids to the oligosaccharide component of glycoconjugates and is a required component of sialylation pathways. CMP-NeuAc synthetase-deficient mutants do not express sialylated glycoconjugates and can be complemented with functional CMP-NeuAc synthetase in both mammalian (1) and bacterial systems (2) . Sialic acids participate in a myriad of signaling, recognition, and cell-cell adhesion phenomena in mammalian cells (3) and are overexpressed in some highly malignant tumors (4) . Genetic disorders that lead to altered physiological levels of sialic acids have many consequences in humans and can be fatal (5) . In bacterial systems, sialic acids are less common and frequently have roles as virulence factors (6) . In Neisseria gonorrhoeae, sialylated glycoconjugates protect the organism from phagocytosis and increase serum resistance (7) . In Haemophilus ducreyi the presence of 2-keto-3-deoxy-manno-octulosonate-containing glycoconjugates correlate with the organism's pathogenicity (8) . Likewise, the sialylated capsule of Neisseria meningitidis, Escherichia coli K1, and group B streptococci are virulence factors (9) (10) (11) . It has been suggested that bacterial species produce sialylated glycoconjugates to mimic the host and escape detection by the immune system (12) . Clearly, the mechanism of production of sialic acid-containing glycoconjugates is of clinical interest. Although bacterial and eucaryotic CMPNeuAc synthetase enzymes share many catalytic properties, several important differences have been reported, including substrate specificity, tertiary structure, inhibitor sensitivity, and cellular localization (13) . As a result, bacterial CMP-NeuAc synthetase enzymes can be targeted by rational drug design strategies.
CMP-NeuAc synthetase is also of considerable interest in the field of biotechnology. In the presence of Mg 2ϩ , CMP-NeuAc synthetase utilizes CTP and acylneuraminate (NeuAc, a sialic acid) as substrates and produces pyrophosphate and cytosine-5Ј-monophosphate acylneuraminate (CMP-NeuAc or CMP-NANA), an "activated" sugar nucleotide monophosphate ( Fig. 1) (14, 15) . The reaction catalyzed by CMP-NeuAc synthetase (and homologous enzymes) is unique in that sialic acid is directly coupled to a cytosine monophosphate. All other activated sugar nucleotide synthetases use a phosphorylated sugar substrate and produce a sugar nucleotide diphosphate (16) . Given the expense of chemically synthesizing CMP-NeuAc and its instability, CMP-NeuAc synthetase together with various sialyltransferases are valuable for the preparative enzymatic synthesis of biologically relevant, sialylated oligosaccharides (17) . In turn, these sialylated oligosaccharides are used in clinical medicine and are invaluable tools for the study of the many processes that require sialic acids.
In this work, the refined x-ray crystallographic structures of selenomethionyl CMP-NeuAc synthetase and CMP-NeuAc synthetase in complex with the substrate analogue CDP (CMPNeuAc synthetase-CDP) are reported. The active site and substrate binding sites for this class of enzyme are described in detail for the first time, and a comparison of the two structures indicates substrate binding is accompanied by significant conformational rearrangements within the active site.
EXPERIMENTAL PROCEDURES
Protein Purification-Recombinant CMP-NeuAc synthetase was overexpressed in E. coli and purified using published protocols (18) with modifications. Briefly we used a combination of anion-exchange on a MonoQ column (Amersham Pharmacia Biotech) and gel filtration on a Superose 12 column (Amersham Pharmacia Biotech). Selenomethionyl * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. § Present address: Dept. of Chemistry and Biochemistry, University of Lethbridge, 4401 University Dr., Lethbridge T1K 3M4, Canada.
ʈ To whom correspondence should be addressed: Tel.: 604-221-0789; Fax: 604-221-5227; E-mail: natalie@byron.biochem.ubc.ca. 1 The abbreviations used are: CMP-NeuAc synthetase, CMP-acylneuraminate synthetase or cytosine-5Ј-monophosphate-N-acetyl neuraminic acid synthetase; CMP-NeuAc, cytosine-5Ј-monophosphate-Nacetyl neuraminic acid; MAD, multiple wavelength anomalous dispersion; NeuAc, acylneuraminate; CMPKDOS, cytosine-5Ј-monophosphate-2-keto-3-deoxy-manno-octonate synthetase; KDO, 2-keto-3-deoxy-manno-octonate; r.m.s., root mean square.
CMP-NeuAc synthetase was overexpressed in a methionine auxotroph of E. coli (WA-834) grown in a defined medium containing 40 mg liter Ϫ1 selenomethionine (19) and purified using the same protocol. All protein samples were purified to homogeneity and were of the expected molecular mass as judged by mass spectrometry and SDS-polyacrylamide gel electrophoresis.
Crystallization and Data Collection-All crystals used in this work were grown by vapor diffusion using hanging drops consisting of 3 l of protein stock (5.0 mg ml Ϫ1 in 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM dithiothreitol, and 0.1 mM EDTA) and 3 l of reservoir solution. Crystals of CMP-NeuAc synthetase and CMP-NeuAc synthetase-CDP were both grown over reservoir solutions composed of 16% polyethylene glycol 2000, 100 mM Tris-HCl, pH 8.0, 10 mM MgCl 2 and 1 mM dithiothreitol. The CMP-NeuAc synthetase crystals grow in 2-3 days, are orthorhombic (space group, P2 1 2 1 2 1 ; unit cell, a ϭ 42.99, b ϭ 59.52, c ϭ 157.56 Å; ␣ ϭ ␤ ϭ ␥ ϭ 90°), and a 2.0-Å resolution data set has been collected at Brookhaven National Laboratory in the Biology Department single-crystal diffraction facility at beamline X8-C in the National Synchrotron Light Source. Orthorhombic crystals of CMP-NeuAc synthetase-CDP were grown in the presence of 10 mM CDP (unit cell, a ϭ 43.01, b ϭ 69.89, c ϭ 157.78 Å; ␣ ϭ ␤ ϭ ␥ ϭ 90°), appeared after 7 days, and diffracted to 2.2 Å on a local Rigaku RU200 rotating anode (50 kV, 100 mA) equipped with OSMIC mirrors. All CMP-NeuAc synthetase crystals in this work were rod-shaped and the largest crystals grew to ϳ0.80 ϫ 0.15 ϫ 0.15 mm in size. All intensity data sets were collected at 100 K after flash-freezing in mother liquor containing 22% glycerol. Intensity data collection and processing statistics for each data set used in this work are summarized in Table I .
Structure Solution-The structure of the CMP-NeuAc synthetase homodimer was determined by MAD phasing based on 10 selenium atom positions. The Se atom positions were identified using both SHAKE'NЈBAKE (20) and SOLVE (21) and subjected to positional, isotropic B-factor, and occupancy refinement within SOLVE prior to the calculation of phases (Table I ). The initial phase estimates were improved by density modification using DM (22) prior to calculation of a 2.0-Å MAD phased electron density map. The initial electron density map is easily interpretable and an initial trace of the CMP-NeuAc synthetase main chain was generated within XTALVIEW (23) . The CMP-NeuAc synthetase-CDP structure was determined by molecular replacement using the CMP-NeuAc synthetase model and the program AMORE (24). Both, CMP-NeuAc synthetase 2 and CMP-NeuAc synthetase-CDP 3 were refined using CNS 1.0 (25) , and all interactive fitting of the models made use of XTALVIEW. (27) were used to identify secondary structures and to check the stereochemical quality of both models throughout the refinement. SURFACE (22) and GRASP (28) were utilized to examine the molecular surface of the models and to examine the local environment of specific residues. XTALVIEW was used for various least-squares superpositions and DOCKVISION (29) was used for the NeuAc modeling. Docking made use of an energy-minimized acylneuraminate structure derived from Protein Data Bank accession code 1WIA and the refined CMP-NeuAc synthetase-CDP model. The starting NeuAc model was used to generate all common NeuAc conformations, and all conformations were docked (10,000 -50,000 trials) against a static CMPNeuAc synthetase-CDP model using either an energy term or conformational energy terms as a scoring function. The best docking results were obtained using CMP-NeuAc synthetase-CDP and CDP conformation I. The figures were prepared using GRASP (28) and MOLSCRIPT (30) .
RESULTS AND DISCUSSION
Overall Fold-The overall fold of the CMP-NeuAc synthetase-CDP homodimer is presented in Fig. 2 . The CMP-NeuAc synthetase monomer is composed of an ϳ190 residue, globular ␣/␤ domain (ϳ50 ϫ 50 ϫ 40 Å) that is structurally classified as an ␣␤␣, three-layered sandwich (31) and a small 35-residue domain that is directed away from the rest of the monomer and forms an extended dimerization interface. The dimerization domains of each monomer wrap around one another in a tight interaction and make contacts with the globular ␣/␤ domain of the opposite monomer. The resulting functional homodimer is highly asymmetric with dimensions of ϳ85 ϫ 45 ϫ 40 Å.
A twisted, central ␤-sheet forms the hydrophobic core of the ␣/␤ domain of the monomer and is flanked by helices giving rise to the ␣␤␣, three-layered sandwich structure. The ␤-sheet contains six parallel ␤ strands (␤1, ␤4, ␤5, ␤6, ␤7, ␤11) and a single antiparallel ␤ strand (␤10) connected with a Ϫ1x, Ϫ1x, ϩ3x, ϩ2x, Ϫ1x, ϩ2x topology (32) . The connectivity of consecutive parallel ␤ strands is right-handed except for a relatively rare left-handed linkage between strand ␤6 and strand ␤7. Alignments of known CMP-NeuAc synthetase sequences (33) indicate that residues between strands ␤6 and ␤7 (102-110) are among the most highly conserved in the comparison (Fig. 3) . Three ␣ helices (B, C, F) pack against and bury the face of the central ␤-sheet furthest from the dimerization interface. The remaining face of the ␤-sheet is covered by two ␣ helices (E, H) and contacts with the dimerization domain of the opposite monomer. The 3 10 helix A, a short ␤ ribbon (␤2, ␤3), 3 10 helix D, and ␣ helix I are all located on the C-terminal side of the mostly parallel, central ␤-sheet. These secondary structures and their associated loops form a deep pocket at the C-terminal ends of the ␤-sheet that is the mononucleotide-binding pocket. The presence of a substrate-binding pocket at the C-terminal ends of predominantly parallel ␤-sheets is a recurring theme in structural biology (34) .
The dimerization domain contains a 3 10 helix (helix G) and a ␤ ribbon (strand ␤8 and strand ␤9) that is continuous with the central ␤-sheet of the opposite monomer. The dimerization domain is located between strands ␤7 and ␤10 and is directed away from the rest of the ␣/␤ domain by a ␤-bulge at position 175 of strand ␤10. In the homodimer, a ␤-bulge in strand ␤10 facilitates an antiparallel hydrogen-bonding network between the N terminus of strand ␤10 and strand ␤8 of the opposite monomer. The dimerization interface buries a large surface area despite its modest size. Using a probe radius of 1.4 Å, a single monomer buries ϳ1450 Å 2 in the dimer (35) . A search of representative structures in the Protein Data Bank using the DALI server (36) indicates the CMP-NeuAc synthetase overall fold has only limited homology with other known folds in the Protein Data Bank. In general, enzymes containing a mononucleotide-binding (Rossman) fold (37) ␤6 and ␤7. The similarities between the N terminus of CMPNeuAc synthetase and Rossman fold containing proteins are restricted to the order and connectivity of secondary structures, because CMP-NeuAc synthetase and related enzymes have unique mononucleotide-binding pockets. The CMP-NeuAc synthetase ␣/␤ domain fold is similar to that reported for cytosine-5Ј-monophosphate-2-keto-3-deoxy-manno-octonate synthetase (CMPKDOS (38) ), a homologous, dimeric enzyme that synthesizes a related, activated sugar compound, cytosine-5Ј-monophosphate 2-keto-3-deoxy-manno-octonate (CMP-KDO). These two enzymes are similar in length but share limited amino acid sequence identity (18%, Fig. 3) , and the fold of the CMPKDOS dimerization domain is significantly different from the equivalent structure in this work. In the CMPKDOS monomer, the dimerization domain is globular and compact and does not make contacts with the ␣/␤ domain of the opposite monomer. Despite the differences in the dimerization interface, both enzymes share a highly asymmetric overall shape. Because the CMPKDOS coordinates are yet to be released and were not made available to us, we cannot present a detailed comparison of the CMP-NeuAc synthetase and CMPKDOS overall folds.
Comparison of CMP-NeuAc Synthetase and CMP-NeuAc Synthetase-CDP-The two monomers of CMP-NeuAc synthetase-CDP in the asymmetric unit have nearly identical mainchain conformations. The monomers superpose with an r.m.s. deviation of 0.60 Å when considering all common main-chain atoms (888 of 912 atoms). Similarly, there are no large-scale conformational differences in a comparison of the CMP-NeuAc synthetase-and CMP-NeuAc synthetase-CDP-refined models and the two homodimers superpose with an r.m.s. deviation of 0.71 Å for 1728 equivalent main-chain atoms (Fig. 4) . The most prominent differences in a comparison of the two refined models occur in the mononucleotide-binding pocket. In the unligan- ded CMP-NeuAc synthetase structure, the P-loop (residues 10 -22) and residues following strand ␤5 (71-80) have relatively weak electron density or are fully disordered in the refined maps. In the CMP-NeuAc synthetase-CDP structure, the equivalent residues make specific contacts with the bound substrate analogue (Table III and see Fig. 6 ) either directly or through ordered solvent molecules, and have well ordered electron density in the refined maps. The average main-chain temperature factors for residues 10 -22 and 71-80 of CMPNeuAc synthetase-CDP and CMP-NeuAc synthetase are 33.1 Å 2 (184 atoms) and 50.3 Å 2 (128 atoms), respectively. In CMPNeuAc synthetase-CDP, the P-loop primarily interacts with the ribose and phosphate moieties of the substrate analogue, whereas residues 71-80 are responsible for base recognition. At the same time, these residues make relatively few specific contacts with the remainder of the enzyme. Apparently, CDP itself provides specific contacts that allow these residues to fold about the mononucleotide substrate analogue and become relatively ordered. Consequently, we propose mononucleotide binding is accompanied by a conformational rearrangement that orders both the P-loop and residues 71-80. This model of substrate binding can account for the observed differences in the refined electron density of the two structures and the observed depth of the mononucleotide-binding pocket. It also explains the ordered bi bi kinetic mechanism (CTP binds first and CMP-NeuAc dissociates last) observed in the homologous enzyme from H. ducreyi (39) . The P-loop and residues 71-80 contain 7 of the 13 invariant residues in an alignment of known bacterial CMP-NeuAc synthetase enzymes (Fig. 3) . In agreement with this work, amino acid sequence analysis, site-directed mutagenesis, and chemical modification studies indicate residues 10 -22 (phosphate binding loop or P-loop) following strand ␤1 are integral components of the mononucleotide-binding pocket (33, 40) . Likewise, in the CMPKDOS structure (38) , residues of the P-loop were observed to bind a heavy atom derivative (IrCl 6 3Ϫ ), and the authors speculated that these residues play a role in phosphate binding.
Mononucleotide Binding Pocket-The molecular surface of CMP-NeuAc synthetase in the presence of CDP is shown in Fig. 5 . The large cleft at the C-terminal end of the central ␤-sheet is the mononucleotide-binding pocket. The cleft is formed by residues following strand ␤1 (P-loop), strand ␤5 (71-80), and strand ␤11 (208 -212). Polar residues line the cleft and are responsible for binding the nucleotide substrate (Fig. 6 and Table III ). As shown in Fig. 7 , the substrate analogue, CDP, is bound in the mononucleotide-binding pocket in two distinct conformations. The cytosine base and ribose moiety are equivalent in the two conformations, whereas the ␣ and ␤ phosphoryl groups adopt different conformations (I, II) as a result of differences in the C4Ј-C5Ј-O5Ј-P1A and C5Ј-O5Ј-P1A-O3A torsion angles. 
HI (H. influenza), HD (H. ducreyi), NM (N. meningitidis), AC (Aeromonas caviae), CC (Campylobacter coli), EC (E. coli), SA (Streptococcus agalactiae), HP (Helicobacter pylori), KDS (CMPK-DOS from H. influenzae).

FIG. 4. CMP-NeuAc synthetase active site in the presence and absence of CDP.
The CMP-NeuAc synthetase-CDP (blue strands and green helices) and CMP-NeuAc synthetase (dark orange strands and red helices) structures superpose with a r.m.s. deviation of 0.71 Å for all common main-chain atoms, and the only relatively, large conformation differences are associated with residues implicated in mononucleotide binding. In the presence of CDP, the P-loop and helix D (light green ribbon) are well ordered and directly contact the bound substrate analogue. In the absence of CDP, the equivalent residues are poorly ordered (P-loop) or disordered (helix D). This suggests substrate binding is accompanied by conformational rearrangements that orders residues involved in mononucleotide binding. The cytosine base is completely buried (521 Å 2 ) in the deep cleft, and its position is fixed by a series of hydrogen bonds. The N 1 and N 2 atoms of the invariant Arg-71 donate hydrogen bonds to O2 and N3 of the base and give rise to the enzymes specificity for cytosine nucleotides. Arg-12 N also donates a hydrogen bond to O2 while Ala-80 O and an ordered solvent molecule accept hydrogen bonds from N4. These interactions completely satisfy the hydrogen bonding potential of the base. The cytosine base orientation is further fixed by van der Waals contacts with the Leu-10 side chain and a stacking interaction with the Arg-12 guanidinium. Together, the Leu-10 and Arg-12 side chains form a narrow pocket that contacts both faces of the base. The residues that bind or contact the cytosine base are all derived from the P-loop and residues following strand ␤5 (71-80). These are the same regions that are largely disordered in the CMP-NeuAc synthetase structure determined in the absence of a substrate analogue. The hydrogen bonding potential of the ribose O2Ј and O3Ј atoms are satisfied by Asn-22 N ␦2 and O ␦1 , respectively. Residues Gln-104, Pro-105, and Thr-106 form the remainder of the ribose subsite of the mononucleotidebinding pocket and are part of the conserved left-handed linkage between strand ␤6 and strand ␤7. Leu-10, Arg-12, and several ordered solvent molecules also contribute to the ribose subsite. Residues of the P-loop are the most highly conserved in sequence alignments of bacterial CMP-NeuAc synthetase enzymes and residues Arg-12, Ser-15, Lys-16, Lys-21, and Asn-22 are invariant in these alignments (Fig. 3) .
Notably, Lys-16 and Asn-22 are not conserved in CMPKDOS sequences. Whereas it has been demonstrated that Lys-16 is not essential for CMP-NeuAc synthetase activity (40) , catalysis is more efficient in the Lys-16-containing holoenzyme. The lack of conservation of Asn-22 is more difficult to understand. In CMP-NeuAc synthetase, Asn-22 hydrogen bonds to the O2Ј and O3Ј atoms of the ribose moiety and apparently discriminates between CTP and dCTP. CMPKDOS has a proline residue at the equivalent position in amino acid sequence alignments. Clearly, proline is unable to specifically interact with the ribose in a manner similar to that observed in CMP-NeuAc synthetase. In the absence of a description of the CMPKDOS active site it is unclear how CMPKDOS specifically binds the ribose moiety and discriminates between CTP and dCTP.
The two conformations of the ␣ and ␤ phosphoryl groups of the substrate analogue CDP are a result of differences in the torsion angles about the C5Ј-O5Ј and O5Ј-P1A bonds (Fig. 7) , respectively. They have been modeled as equivalent conformations during the refinement and have comparable average isotropic B-factors. Conformation I of the ␣ and ␤ phosphoryl group has a C4Ј-C5Ј-O5Ј-P1A torsion angle of Ϫ115°and a C5Ј-O5Ј-P1A-O3A torsion angle 155°, whereas conformation II has torsion angles of Ϫ160°and 50°, respectively. Several observations strongly suggest that conformation I closely mimics that of the substrate, CTP: (a) the presence of an oxyanionhole-like structure formed by Ser-15 N and Gly-17 N that is adjacent to the ␤ phosphate and is suitably positioned to interact with a ␥ phosphate, (b) the presence of a potential Mg 2ϩ -binding site bridging the phosphoryl groups of the substrate and including the relatively conserved Asp-209 and Asp-211, and (c) the number and nature of the contacts between CMPNeuAc synthetase and the substrate analogue phosphoryl groups (Table III and Fig. 6 ). Additionally, in conformation I a single, ordered water molecule (Wat-160) hydrogen bonding to Asn-14 O and the ␤ phosphate, is suitably positioned to donate a hydrogen to the pyrophosphate leaving group. In CDP con- formation II, there are no apparent ␥ phosphate-or Mg 2ϩ -binding sites and relatively fewer contacts between the enzyme and phosphoryl groups. Why then do we observe conformation II in this work? The C4Ј-C5Ј-O5Ј-P1A dihedral angle (conformation II) adopts a staggered conformation and relieves the stereochemical strain arising from the eclipsed C4Ј-C5Ј-O5Ј-P1A dihedral angle present in conformation I. The absence of a binding site for the ␥ phosphate in conformation II suggests CTP will not bind in two distinct, equally populated conformations as observed with CDP.
The bulk of the interactions with phosphate moieties, in conformation I, are from residues of the P-loop. This is similar to the case for many Rossman fold proteins, which also have a phosphate binding or P-loop immediately following their Nterminal ␤ strand. However, the details of the interaction between the P-loop and the base and phosphate are very different in these two groups of enzymes. This is not surprising because CMP-NeuAc synthetase releases pyrophosphate as a product, whereas kinases, G-proteins, and other Rossman fold-containing proteins release a single phosphate, the ␥ phosphoryl group (37) . In conformation II, there are fewer contacts between the phosphates and the protein.
NeuAc Binding Pocket-As seen in Fig. 5 , the active site cleft of CMP-NeuAc synthetase extends beyond the mononucleotidebinding pocket toward the dimerization domain and forms the NeuAc-binding pocket. The pocket is lined with a number of polar side chains (Fig. 5, 6 ) and can easily accommodate NeuAc. Atoms O4 and O9 and the NeuAc carboxylate are solventexposed and may interact with ordered solvent molecules in addition to CMP-NeuAc synthetase. Alternatively, substrate binding may involve a small conformational change in CMPNeuAc synthetase that decreases the volume of the binding pocket. The polar side chains of residues Ser-82, Gln-104, Thr-106, and Asp-209 line the NeuAc pocket nearest the bound substrate analogue (CDP), whereas Tyr-179 and residues Glu-137, Lys-142, Glu-162, and Arg-165 from the dimerization domain of the opposite monomer form the edges of the binding pocket furthest from the bound CDP. Interestingly, 4 of the 9 polar residues within the proposed NeuAc-binding pocket are derived from residues of the dimerization domain. This implies that the sequence and structure of the dimerization domain is an important determinant for the discrimination of various sialic acids. Thus, the dimerization domains of homologous enzymes with specificities for related sialic acid derivatives are likely to have limited amino acid sequence identity and adopt a conformation different from that observed in CMP-NeuAc synthetase. As pointed out earlier, the dimerization interfaces of CMP-NeuAc synthetase and CMPKDOS are very different, and sequence alignments indicate the dimerization domains of CMP-NeuAc synthetase enzymes are not highly conserved (35, Fig. 3) .
NeuAc Modeling-A model of an energy-minimized NeuAc that has been docked in the NeuAc-binding pocket is presented in Fig. 8 . The docked NeuAc model produces the lowest energy using either the DockVision energy function (Ϫ31.04 kJ) or conformational energy function (Ϫ9.40 kJ). In the docked model, the NeuAc functional groups make a number of plausible interactions with invariant or conserved residues (Figs. 6 and 8). The axial, O2 atom of NeuAc is directed at the ␣ phosphate of the biologically significant CDP conformer (conformation I) in accordance with the known specificity of CMPNeuAc synthetase (41) . The NeuAc C2 carboxylate (a strong acid) is directed away from the cleft and forms a salt bridge with the Arg-165 guanidinium in the model. As seen in Fig. 3 , a positively charged amino acid able to counter the negative charge of the C2 carboxylate is present at positions 164 or 165 of each amino acid sequence. The N-acetyl group at C5 of NeuAc docks with the acetyl oxygen exposed to bulk solvent, the nitrogen atom hydrogen bonding with Gln-104 O ⑀ and the methyl group packing against the aromatic residues Tyr-179, Phe-192, and Phe-193. Although, these residues are all conserved among CMP-NeuAc synthetase enzymes (Fig. 3) , only Gln-104 is conserved between CMP-NeuAc synthetase and CMPKDOS enzymes. This is reasonable because KDO, the CMPKDOS substrate, has a hydroxyl at position C5 (equivalent to the nitrogen of NeuAc) but has no counterpart to the carbonyl oxygen and methyl group of NeuAc. Consequently, only the Gln-104 interaction with the C5 substituent is expected to be conserved between these enzymes.
The O4 atom of NeuAc is paired with the Ser-82 OH in this model and may also interact with the Ala-80 N. At the base of the binding pocket, the Gln-104 side chain contacts both the O8 and N5 atoms of NeuAc model and is suitably positioned to help CMP-NeuAc synthetase discriminate between the sialic acids with variable C6 functional groups. The O8 atom is also within contact distance of the Asp-209 carboxylate. The O7 atom and O9 atoms of NeuAc are directed at the dimerization domain of the opposite monomer and are within hydrogen-bonding distances of the Lys-142 and Tyr-179 side chains. Additional residues may interact with the NeuAc model via bridging solvent molecules or may directly interact with NeuAc if CMP-NeuAc synthetase undergoes a small conformational change upon substrate binding.
In the CMP-NeuAc synthetase reaction mechanism, the O2 atom of NeuAc is the nucleophile in an S N 2 attack on the ␣ phosphate (41). Our structure and docking results support this mechanism and we predict the leaving group pyrophosphate is stabilized by the absolutely conserved Arg-12, Lys-21, one or more bridging Mg 2ϩ cations, and possibly the conserved Lys-16 (Fig. 3) . As previously mentioned, an ordered solvent molecule hydrogen bonding to Asn-14 O is suitably positioned to donate a hydrogen bond to the leaving group pyrophosphate. In the model, the nucleophilic NeuAc O2 atom is not within hydrogenbonding distance of any atom of the enzyme and, consequently, there is no readily apparent general base. An ordered solvent molecule may serve as the general base or, alternatively, a conformational rearrangement may bring a general base within hydrogen-bonding distance of the O2 atom upon NeuAc binding. We favor a mechanism in which an ordered solvent molecule serves as the general base, because it seems unlikely that a conformational rearrangement could bring a protein atom within hydrogen-bonding distance of the NeuAc O2 atom without disrupting the specific interactions detailed above.
